Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
PDS Biotech will host a virtual KOL event on Oct. 15, 2026, discussing Phase 2 clinical outcomes for PDS0301 in advanced liver-associated cancers, including metastatic colorectal cancer.
PDS Biotechnology Corporation will host a virtual Key Opinion Leader (KOL) event on October 15, 2026, to discuss PDS0301 for the treatment of advanced colorectal cancer with liver metastases. The event will feature Jonathan M. Hernandez, M.D.